Return to Article Details EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS Download Download PDF